Tri Locum Partners as of Dec. 31, 2023
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 24 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 11.9 | $26M | 168k | 154.97 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 8.6 | $19M | 1.8M | 10.44 | |
| Kenvue Put Option (KVUE) | 6.9 | $15M | 699k | 21.53 | |
| Regeneron Pharmaceuticals (REGN) | 6.4 | $14M | 16k | 878.29 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 6.1 | $13M | 172k | 77.32 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.7 | $13M | 100k | 125.95 | |
| Avadel Pharmaceuticals Sponsored Adr | 5.4 | $12M | 840k | 14.12 | |
| Biogen Idec (BIIB) | 5.4 | $12M | 46k | 258.77 | |
| Catalent (CTLT) | 5.4 | $12M | 262k | 44.93 | |
| Axsome Therapeutics (AXSM) | 4.8 | $10M | 131k | 79.59 | |
| Xenon Pharmaceuticals (XENE) | 4.7 | $10M | 226k | 46.06 | |
| Argenx Se Sponsored Adr (ARGX) | 4.2 | $9.2M | 24k | 380.43 | |
| Natera (NTRA) | 4.1 | $8.9M | 142k | 62.64 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.8 | $6.2M | 102k | 60.17 | |
| Madrigal Pharmaceuticals (MDGL) | 2.7 | $5.9M | 26k | 231.38 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.7 | $5.8M | 293k | 19.88 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.5 | $5.5M | 249k | 22.28 | |
| Astria Therapeutics (ATXS) | 1.9 | $4.2M | 543k | 7.68 | |
| Astrazeneca Sponsored Adr (AZN) | 1.8 | $4.0M | 59k | 67.35 | |
| Scholar Rock Hldg Corp (SRRK) | 1.8 | $3.9M | 207k | 18.80 | |
| Arcturus Therapeutics Hldg I (ARCT) | 1.6 | $3.5M | 111k | 31.53 | |
| Immatics SHS (IMTX) | 1.3 | $2.9M | 276k | 10.53 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.3 | $2.9M | 48k | 60.39 | |
| Femasys (FEMY) | 0.0 | $35k | 36k | 0.97 |
